Bookedited by David W. Dempster, Jane A. Cauley, Mary L. Bouxsein, Felicia Cosman.
Contents:
-- Volume 1. Part I. Introduction. The nature of osteoporosis
The bone organ system: form and function
Part II. Developmental, cellular and molecular biology of bone. Development of the skeleton
The skeletal stem cell
Osteoclast biology
Osteoblast biology: developmental origin and interactive nature of osteoblasts
Osteocytes
The regulatory role of matrix proteins in mineralization of bone
Part III. Skeletal hormones and regulatory factors. Parathyroid hormone and parathyroid hormone-related protein
Phosphatonins
Skeletal growth factors
WNT signaling in skeletal homeostasis and diseases
Part IV. Biomechanics and mechanobiology. The mechanical behavior of bone
Cellular and molecular mechanotransduction in bone
Adaptation of skeletal structure to mechanical loading
Biomechanics of hip and vertebral fractures
Part V. Epidemiology of osteoporosis. Epidemiologic methods in studies of osteoporosis
Genetics of osteoporosis
Race, ethnicity, and osteoporosis
Geographic variability in the incidence of hip and vertebral fractures
Nutrition and osteoporosis
Physical activity, exercise and skeletal health
Reproductive and hormonal factors and the risk for osteoporosis
Clinical and epidemiological studies: skeletal changes across menopause
Osteoporosis in men: what is similar and what is different?
Falls as risk factors for fracture
Impact of physical characteristics and lifestyle factors on bone density and fractures
Imminent fracture risk and disability post fracture
Economics of osteopososis
Part VI. General pathophysiology of osteoporosis. Skeletal heterogeneity and the purposes of bone remodeling
On the evolution and contemporary roles of bone remodeling
Estrogen deficiency and the pathogenesis of osteoporosis
Cytokines and the pathogenesis of osteoporosis
Bone and fat
Bone, muscle, and sarcopenia
Bone mineral acquisition in utero and during infancy and childhood
Osteoporosis in childhood and adolescence
Osteoporosis in premenopausal women, pregnancy, and lactation
Bone and the microbiome
Volume 2. Part VII. Impact of comorbidity and medications on skeletal health. Immobilization osteoporosis
Osteoporosis in neurological disorders: Parkinson’s disease, stroke, and multiple sclerosis
Effects on the skeleton from medications used to treat non-skeletal disorders
Osteoporosis associated with gastrointestinal disorders; celiac and inflammatory bowel diseases
Osteoporosis associated with eating disorders
Glucocorticoid-induced osteoporosis and Cushing's syndrome
Thyroid hormone, thyroid medication, and the skeleton
The skeletal actions of parathyroid hormone in primary hyperparathyroidism
Osteogenesis imperfecta and other defects of bone development as occasional causes of adult osteoporosis
Human immunodeficiency virus and osteoporosis
Diabetes, diabetic medications, and risk of fracture
Skeletal health after bariatric surgery
Osteoporosis in organ transplant patients
Osteoporosis associated with rheumatologic disorders
Osteoporosis associated with chronic kidney disease
Relationship between periodontal disease, tooth loss and osteoporosis
Impact of breast cancer and its treatment on bone loss and fracture risk – pathophysiology and management
Management of bone health in men with prostate cancer
Impact of MGUS and myeloma on skeletal health
Renal stone disease, hypercalciuria and osteoporosis: use of thiazides and alkali for osteoporosis
Sleep disorders and osteoporosis
Part VIII. Diagnosis and evaluation. Evaluation of the osteoporosis patient
Who should be screened for osteoporosis?
Vertebral fracture identification
Noninvasive imaging techniques and fracture risk assessment
Biochemical markers of bone turnover in osteoporosis
A comparison of fracture risk assessment tools
Part IX. Patient management. Orthopedic aspects of osteoporosis
Fall prevention interventions
Exercise and other physical therapy interventions in the management of osteoporosis
Calcium and vitamin d in the management of osteoporosis
Nutrients beyond calcium and vitamin d to treat osteoporosis
Condition still critical: compliance and persistence with osteoporosis medications
Part X. Pharmacotherapeutics. Estrogen and estrogen analogs for prevention and treatment of osteoporosis
Bisphosphonates pharmacology and use in the treatment of osteoporosis
Denosumab for the treatment of osteoporosis
Teriparatide and abaloparatide treatment for osteoporosis
Calcitonin in osteoporosis
Androgens
Long-term bisphosphonate treatment: continuation and interruption
Romosozumab in the treatment of postmenopausal osteoporosis
Lessons from bone histomorphometry on the mechanisms of action of osteoporosis drugs
Part XI. New directions. Long term treatment strategies and goal directed therapy.
RequestLocation
Version
Call Number
Items
Books: General Collection (Downstairs)
RC648 .O85 2021
2